SCHEMBL8069945

SCHEMBL8069945

Cc1cc2cccc3c2n1C(CN1CCOCC1)CO3

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 7/20 0.56
CNR2 P34972 7/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
ALDH1A1 P00352 3/20 0.56
MAPT P10636 1/20 0.56
NPC1 O15118 1/20 0.56
MTOR P42345 1/20 0.56
RAB9A P51151 1/20 0.56
RGS12 O14924 1/20 0.52
GMNN O75496 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
CYP2D6 P10635 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9700209 0.89 CNR1 (0.46) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL6558235 0.79 CNR1 (0.39) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL27493751 0.77 CNR1 (0.50) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL9700471 0.77 CNR2 (0.35) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL18258131 0.74 SMN1; SMN2 (0.35) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL31297105 0.74 CNR1 (0.61) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL3458112 0.73 CNR1 (1.00) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL9700346 0.73 CNR1 (1.00) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL14536818 0.73 CNR1 (0.62) CNR1CNR2CYP3A4CYP2C9MEN1
Win-552122 SCHEMBL3680086 0.72 CNR1 (1.00) CNR1CNR2CYP3A4CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US claimed
WO-1990007505-A1 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES STERLING DRUG INC. (US) 1990-07-12 WO claimed
US-6013648-A IMMUNOMODULATORS SANOFI (FR) 2000-01-11 US disclosed
EP-0833818-A1 CB 2? RECEPTOR AGONIST COMPOUNDS SANOFI (FR) 1998-04-08 EP disclosed
WO-1997000860-A1 CB2 RECEPTOR AGONIST COMPOUNDS SANOFI (FR) 1997-01-09 WO disclosed
US-5112820-A Vision defects STERLING DRUG INC. (US) 1992-05-12 US disclosed
US-5109135-A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates STERLING DRUG INC. (US) 1992-04-28 US disclosed
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US disclosed
WO-1990007505-A1 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES STERLING DRUG INC. (US) 1990-07-12 WO disclosed
US-4939138-A 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines STERLING DRUG INC. (US) 1990-07-03 US disclosed